The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer

BACKGROUND: Several classification systems are available to assess pathological response to neoadjuvant chemotherapy in breast cancer, but reliable biomarkers to predict the efficiency of primary systemic therapy (PST) are still missing. Deregulation of gap junction channel forming connexins (Cx) ha...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Teleki, Ivett, Krenacs, Tibor, Szasz, Marcell A, Kulka, Janina, Wichmann, Barna, Leo, Cornelia, Papassotiropoulos, Barbel, Riemenschnitter, Cosima, Moch, Holger, Varga, Zsuzsanna
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2013
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3583680/
https://ncbi.nlm.nih.gov/pubmed/23374644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-50
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares